CA984293A - Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom - Google Patents
Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefromInfo
- Publication number
- CA984293A CA984293A CA148,915A CA148915A CA984293A CA 984293 A CA984293 A CA 984293A CA 148915 A CA148915 A CA 148915A CA 984293 A CA984293 A CA 984293A
- Authority
- CA
- Canada
- Prior art keywords
- superiorly
- antigenic
- growth
- medium
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000713730 Equine infectious anemia virus Species 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17338571A | 1971-08-20 | 1971-08-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA984293A true CA984293A (en) | 1976-02-24 |
Family
ID=22631768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA148,915A Expired CA984293A (en) | 1971-08-20 | 1972-08-08 | Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom |
Country Status (3)
Country | Link |
---|---|
AR (2) | AR197385A1 (en) |
CA (1) | CA984293A (en) |
FR (1) | FR2150799A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132709A (en) * | 1990-06-07 | 2000-10-17 | Bayer Corporation | Bacterin for the treatment of necrophorum diseases and a method for the production thereof |
-
1972
- 1972-08-08 CA CA148,915A patent/CA984293A/en not_active Expired
- 1972-08-18 AR AR243625A patent/AR197385A1/en active
- 1972-08-18 FR FR7229567A patent/FR2150799A1/en active Granted
-
1973
- 1973-09-13 AR AR250070A patent/AR197417A1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132709A (en) * | 1990-06-07 | 2000-10-17 | Bayer Corporation | Bacterin for the treatment of necrophorum diseases and a method for the production thereof |
Also Published As
Publication number | Publication date |
---|---|
AR197385A1 (en) | 1974-04-05 |
AR197417A1 (en) | 1974-04-05 |
FR2150799B1 (en) | 1976-07-02 |
FR2150799A1 (en) | 1973-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL43310A0 (en) | Method of immunization for mycoplasma respiratory infections of livestocks,a suspension vaccine therefor and a process for preparing said suspension | |
IL44143A0 (en) | Method of inactivating viruses and vaccines prepared thereby | |
CA984293A (en) | Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom | |
CA975099A (en) | Process for producing homo- and copolymers of cyclic acetals | |
CA983851A (en) | Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same | |
SU579309A1 (en) | Method of preparing vaccine | |
HU173548B (en) | Process for preparing a recombinant strain of influenza virus and a vaccine containing this strain | |
CA958641A (en) | Equine strangles vaccine and method of preparing and using the same | |
CA980251A (en) | Adjuvants for vaccines and vaccine preparations containing them | |
CA952658A (en) | Process of preparing silicates of high porosity and silicates obtained by said process | |
AU5183673A (en) | Method of regulating virus growth | |
CH611338A5 (en) | Process for the preparation of inactivated HB-Ag vaccines | |
CA951742A (en) | Catalytic method for making catechol and alkoxy derivatives thereof | |
CA875820A (en) | Method and apparatus for preparing packages of yarn for subsequent treatment | |
BE791871A (en) | PROCESS FOR PREPARING CYCLIC IMIDO-ACID ESTERS, AND PRODUCTS OBTAINED | |
AU457758B2 (en) | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame | |
CA1024890A (en) | Vaccine comprising equine infectious anemia viral protein coupled to globulin | |
CA864529A (en) | Replicase for viral rna and method of preparing the same | |
CA876692A (en) | Replicase for viral rna and method of preparing the same | |
AU3626071A (en) | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame | |
CA960586A (en) | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same | |
CA867405A (en) | Method of preparing silyl alcohols | |
CA997779A (en) | Method of preparing catechol diacetates | |
AU2793871A (en) | Process for preparing live virus vaccines | |
CA874432A (en) | Polymerization catalyst, method of catalyst preparation and polymerization process |